AXA Investment Managers

Latour Capital, established in 2011, is a French private equity firm headquartered in Paris. It specializes in buyout investments, focusing on small and mid-sized companies across Europe, with a particular interest in the networking, manufacturing, industrial, and commercial services sectors. The firm typically invests in companies valued between EUR 50 million to EUR 200 million, providing majority or minority stakes. Latour Capital works closely with management teams to develop businesses and create value for all stakeholders, leveraging the entrepreneurial spirit and operational knowledge of its investment professionals.

Capza, established in 2004, is a European private investment platform headquartered in Paris, France. It specializes in providing flexible equity and private debt financing to small and mid-cap companies across various sectors, with a focus on healthcare, software, IT services, and e-commerce. Capza manages €2.7 billion in assets and offers four complementary areas of expertise: Flex Equity, Private Debt, Transition, and Artemid Senior Loans. The company is majority-owned by its teams and supported by the AXA Group, with the management team holding a 54% stake. Capza's investment strategy targets companies with an EBITDA range of €2 million to €10 million, aiming to support their growth and development.

Rivage Investment is an independent asset management company established in 2010 and headquartered in Paris, France. The firm specializes in asset and investment management solutions, focusing on private debt and equity derivatives, as well as providing advisory services. Rivage Investment leverages its expertise in European infrastructure and French public sector debt financing to target investments in key sectors, including renewable energy, transport, waste management, telecommunications, and public sector entities such as local authorities, public hospitals, and social housing. The firm is dedicated to combating global warming and has a proven history of financing projects that promote energy transition.

Switchee Limited is a technology company based in London, United Kingdom, specializing in connected devices and analytics for landlords and residents in the social housing sector. Founded in 2014, Switchee has established itself as a market leader by providing an Internet-connected smart thermostat that enables effective management of heating and hot water in homes. The company's solution empowers large residential landlords to optimize their property portfolios by identifying maintenance issues, reducing fuel costs, and enhancing communication with residents. Switchee's thermostat not only helps landlords save money—yielding a return of £2 for every £1 invested—but also fosters improved living conditions by addressing issues like fuel poverty and dampness. The device serves as a two-way communication platform with residents while collecting environmental data that informs a comprehensive insights engine and landlord dashboard. Through its innovative approach, Switchee has transformed the interaction between landlords and residents, making property management more efficient and responsive to the needs of tenants.

Axena Health is a women-led company focused on enhancing the lives of women suffering from pelvic floor disorders through innovative digital technology. The company specializes in women's pelvic health, particularly addressing the medical and social challenges associated with urinary and fecal incontinence. Its flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic designed for at-home treatment of urinary incontinence and chronic fecal incontinence. The system employs patented technology that allows for non-invasive, drug-free treatment by providing real-time visualization of pelvic floor movements while tracking usage and progress. This approach empowers women to strengthen their pelvic floor and alleviate symptoms related to various types of incontinence, including stress, mixed, and urgency incontinence, ultimately improving their quality of life.

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

Iceberg Data Lab is a financial technology company that specializes in providing environmental data solutions to financial institutions. The company focuses on developing assessment tools and methodologies that enable clients to evaluate the environmental impacts of issuers and assets across the entire value chain, from supply chain to end-use. By offering comprehensive insights into the environmental performance of portfolios, Iceberg Data Lab assists financial companies in effectively reporting and managing their environmental impact.

W Capital Partners, established in 2001, is a New York-based private equity firm specializing in secondary investments. It provides liquidity solutions to private company shareholders and other investment firms, focusing on business services, healthcare, and technology sectors across the U.S. and Europe. The firm offers tailored solutions, structuring transactions ranging from $5 to $250 million, and also invests primary capital to support portfolio company growth. W Capital invests across late-stage venture capital, growth equity, and buyout stages, with a diversified portfolio construction approach across various industry sectors.

LimmaTech Biologics is a clinical-stage biotech company focused on developing vaccines to prevent life-threatening diseases. It specializes in creating bioconjugate vaccines through innovative techniques such as glycoengineering and protein glycosylation, which improve the efficiency of vaccine development and address challenges associated with traditional chemical conjugation methods. The company's proprietary self-adjuvanting and multi-antigen vaccine platforms target microbial infections that are increasingly resistant to existing treatments. LimmaTech Biologics is dedicated to expanding its pipeline, aiming to provide effective solutions for infectious diseases that currently have limited treatment options. Through its research and development efforts, the company seeks to enhance healthcare outcomes by delivering tailored vaccines for specific pathogens.

LimmaTech Biologics is a clinical-stage biotech company focused on developing vaccines to prevent life-threatening diseases. It specializes in creating bioconjugate vaccines through innovative techniques such as glycoengineering and protein glycosylation, which improve the efficiency of vaccine development and address challenges associated with traditional chemical conjugation methods. The company's proprietary self-adjuvanting and multi-antigen vaccine platforms target microbial infections that are increasingly resistant to existing treatments. LimmaTech Biologics is dedicated to expanding its pipeline, aiming to provide effective solutions for infectious diseases that currently have limited treatment options. Through its research and development efforts, the company seeks to enhance healthcare outcomes by delivering tailored vaccines for specific pathogens.

ENOUGH is a technology spin-out from the University of Strathclyde focused on developing and commercializing innovative patented technology for the production of mycoprotein, a meat alternative. The company integrates mycoprotein production within existing bio-refinery operations that also produce bio-ethanol and animal feed, promoting a sustainable circular economy. ENOUGH's mycoprotein-based products are designed to be environmentally friendly, utilizing less water and generating lower carbon dioxide emissions while employing a zero-waste fermentation process. This approach allows for the creation of food ingredients that contain all essential amino acids and are high in dietary fiber, providing consumers with a low-cost, sustainable protein option that serves as a meat substitute.

Meva Energy is a Swedish company established in 2008 that specializes in gasification technology for generating renewable energy from small fraction fuels. The company focuses on biomass gasification to produce power and heat energy, which can be utilized for various applications such as heating buildings, melting materials, running engines, and boiling water. By offering a sustainable solution for energy production, Meva Energy enables its clients to achieve profitability while contributing to environmental sustainability.

Finerge is a renewable energy producer dedicated to providing access to sustainable and clean energy sources. The company specializes in the development, construction, and acquisition of wind farms and photovoltaic solar plants. With operations spanning over 46 municipalities in Portugal and three provinces in Spain, Finerge harnesses wind energy and utilizes thousands of photovoltaic modules to generate electricity. Through its initiatives, the company aims to contribute to a cleaner energy landscape and meet the growing demand for renewable energy solutions.

Mombak is a carbon removal company dedicated to reforesting the Amazon through the establishment of native, biodiverse forests. The company employs a team of experts in science, technology, forestry, and carbon markets to implement projects that effectively capture carbon from the atmosphere. Mombak's initiatives are designed to ensure high additionality and durability while minimizing leakage, thereby enhancing biodiversity and supporting socioeconomic development in local communities. Its focus on high-integrity carbon removal aligns with the company's mission to create sustainable environmental solutions.

Helium Health is a technology company focused on transforming healthcare in Africa by providing a comprehensive suite of software solutions for hospitals and clinics. The company specializes in electronic health record systems that facilitate the management of patient data and hospital operations. Its platform simplifies various processes, including doctor visits, prescriptions, and medical billing, making it accessible from any device. Additionally, Helium Health offers customizable forms and tools for monitoring healthcare trends, generating alerts, and producing reports. By leveraging technology, the company aims to create a modern and affordable healthcare system while aspiring to become the largest healthcare data exchange in Africa.

Chloris Geospatial specializes in innovative remote sensing technology aimed at monitoring natural resources and addressing critical natural capital issues. By leveraging advanced remote sensing, machine learning, and ecological science, the company provides precise measurements of carbon stocks, gains, and losses, while also quantifying uncertainty. Their sensor fusion technology offers insights with global scale and accuracy, empowering clients to make informed decisions regarding natural capital management in the face of global climate and environmental challenges. Through these capabilities, Chloris Geospatial plays a vital role in helping organizations understand and mitigate the impacts of climate change and natural resource depletion.

Axena Health is a women-led company focused on enhancing the lives of women suffering from pelvic floor disorders through innovative digital technology. The company specializes in women's pelvic health, particularly addressing the medical and social challenges associated with urinary and fecal incontinence. Its flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic designed for at-home treatment of urinary incontinence and chronic fecal incontinence. The system employs patented technology that allows for non-invasive, drug-free treatment by providing real-time visualization of pelvic floor movements while tracking usage and progress. This approach empowers women to strengthen their pelvic floor and alleviate symptoms related to various types of incontinence, including stress, mixed, and urgency incontinence, ultimately improving their quality of life.

Ophirex is engaged in the development of a novel drug aimed at treating snakebite envenomation, a critical health issue that affects approximately 500,000 individuals annually, with many succumbing to their injuries before reaching medical facilities. The company’s antidote is a small molecule therapeutic that specifically targets the most lethal components of snake venom. Designed for both human and veterinary use, the drug will be made available in an oral formulation, allowing for easy administration in field conditions, where the majority of snakebites occur. This innovative approach promises to provide safe, effective, and accessible initial treatment for victims of snakebites, significantly improving survival rates and outcomes.

CleanFiber, LLC is a manufacturer of cellulose insulation materials designed for use in attics, walls, and floors of both residential and commercial buildings. Founded in 2013 and headquartered in Blasdell, New York, with an additional office in Buffalo, the company specializes in producing high-performance, carbon-negative insulation from recycled corrugated cardboard. This innovative approach not only promotes sustainability but also enables construction companies to build fire-resistant structures while maintaining cost competitiveness. CleanFiber has transitioned from its former name, UltraCell Insulation, LLC, in September 2018, and is currently focused on rapidly scaling up production to meet growing demand in the insulation market.

Eyenuk, Inc. is a medtech company that specializes in artificial intelligence-based retinal image analysis and disease detection technology. Founded in 2010 and headquartered in Woodland Hills, California, Eyenuk develops innovative solutions aimed at enhancing the screening process for various eye diseases. Its flagship product, the EyeArt AI Eye Screening System, is recognized for its autonomous detection of diabetic retinopathy, requiring no expert human grading or eye dilation. The company also offers EyeMark, which monitors retinopathy progression, and EyeApp, a mobile application facilitating diabetic retinopathy screening via smartphones. Additionally, Eyenuk provides EyeSeeAMD, a technology designed to identify age-related macular degeneration. Through its advanced solutions, Eyenuk aims to ensure timely diagnosis of life- and vision-threatening conditions, including glaucoma and cardiovascular risks, ultimately striving to screen every eye globally.

Switchee Limited is a technology company based in London, United Kingdom, specializing in connected devices and analytics for landlords and residents in the social housing sector. Founded in 2014, Switchee has established itself as a market leader by providing an Internet-connected smart thermostat that enables effective management of heating and hot water in homes. The company's solution empowers large residential landlords to optimize their property portfolios by identifying maintenance issues, reducing fuel costs, and enhancing communication with residents. Switchee's thermostat not only helps landlords save money—yielding a return of £2 for every £1 invested—but also fosters improved living conditions by addressing issues like fuel poverty and dampness. The device serves as a two-way communication platform with residents while collecting environmental data that informs a comprehensive insights engine and landlord dashboard. Through its innovative approach, Switchee has transformed the interaction between landlords and residents, making property management more efficient and responsive to the needs of tenants.

X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the discovery and development of innovative therapeutics for primary immune deficiencies and cancer. The company's lead drug candidate, mavorixafor, is an oral small molecule antagonist of the chemokine receptor CXCR4, currently undergoing multiple clinical trials. These include a Phase III trial for patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome, as well as Phase Ib and Phase IIa trials focused on severe congenital neutropenia and clear cell renal cell carcinoma, respectively. In addition, X4 Pharmaceuticals is advancing X4P-002, targeting glioblastoma multiforme, and X4P-003 aimed at primary immune deficiencies. The company has also established a license agreement with Abbisko Therapeutics to develop mavorixafor in combination with checkpoint inhibitors for oncology applications. Founded in 2014, X4 Pharmaceuticals was previously known as Arsanis, Inc. before rebranding in March 2019.

MFS Africa Limited is a leading provider of mobile money interoperability in Africa, facilitating seamless money transfers and payments across the continent. Established in 2009 and headquartered in Accra, Ghana, the company connects mobile network operators through a unified API, enabling a range of services including remittances, merchant and bulk payments, as well as bank-to-wallet transfers. MFS Africa serves various stakeholders, including money transfer operators, banks, and mobile money operators, by offering alternatives for remittances, micro-lending, micro-insurance, and micro-savings. With additional offices in key African cities and London, MFS Africa plays a crucial role in enhancing financial connectivity and promoting financial inclusion across the region.

Carbon Clean Solutions is an innovation company focused on carbon dioxide recovery technology for industrial applications. The company has developed a patented carbon capture technology that enables the removal of up to 90% of carbon dioxide from flue gases, utilizing a proprietary regenerable advanced solvent and an energy-efficient capture process. This technology is designed to be both cost-effective and environmentally friendly, significantly reducing operating costs and impacts for power plants and industrial utilities. Carbon Clean Solutions' technology can be integrated into new power plants or retrofitted to existing facilities, offering clients a scalable solution for decarbonization. With multiple research teams and facilities worldwide, the company is committed to commercializing its energy-efficient carbon capture solutions for a diverse range of global customers.

Sistema.bio is a manufacturer of prefabricated modular biodigester systems aimed at enhancing the efficiency and quality of life for small farmers. The company's systems utilize anaerobic bacteria to convert manure and various organic waste types into methane gas and organic fertilizer. This biogas can be harnessed for thermal energy used in cooking and generating electricity, while the fertilizer supports agricultural productivity. By transforming organic waste into valuable resources, Sistema.bio enables farmers to turn a potential problem into opportunities for increased productivity and sustainability.

ENOUGH is a technology spin-out from the University of Strathclyde focused on developing and commercializing innovative patented technology for the production of mycoprotein, a meat alternative. The company integrates mycoprotein production within existing bio-refinery operations that also produce bio-ethanol and animal feed, promoting a sustainable circular economy. ENOUGH's mycoprotein-based products are designed to be environmentally friendly, utilizing less water and generating lower carbon dioxide emissions while employing a zero-waste fermentation process. This approach allows for the creation of food ingredients that contain all essential amino acids and are high in dietary fiber, providing consumers with a low-cost, sustainable protein option that serves as a meat substitute.

PackBenefit is a European specialist in high-performance fiber-based food packaging, focusing on sustainable solutions for the food industry. The company designs and manufactures recyclable and compostable cellulose trays tailored for commercial catering, fresh food, and food-to-go markets. PackBenefit offers a diverse range of products, including trays, films, and sealers, all produced through its patented thermoforming-coating production process. By emphasizing ecological packaging, PackBenefit provides clients with viable alternatives to traditional plastic packaging, supporting environmentally responsible practices in the food sector.

Sanergy, Inc. focuses on enhancing sanitation infrastructure in urban slums, particularly in Nairobi, Kenya. Established in 2010, the company builds a network of low-cost sanitation centers equipped with essential facilities such as toilets and showers. These centers are then franchised to local entrepreneurs, with financial support from microfinance institutions. Sanergy not only provides access to hygienic sanitation but also collects human waste daily for processing. This waste is converted into valuable byproducts, including organic fertilizers and renewable energy through a biogas generation process. The organic fertilizers are sold to both commercial farms and smallholder farmers, while the generated biogas is used to produce electricity for sale. Sanergy's mission is to promote public health and environmental sustainability by creating an efficient and equitable sanitation system that addresses the needs of underserved urban communities.

Eyenuk, Inc. is a medtech company that specializes in artificial intelligence-based retinal image analysis and disease detection technology. Founded in 2010 and headquartered in Woodland Hills, California, Eyenuk develops innovative solutions aimed at enhancing the screening process for various eye diseases. Its flagship product, the EyeArt AI Eye Screening System, is recognized for its autonomous detection of diabetic retinopathy, requiring no expert human grading or eye dilation. The company also offers EyeMark, which monitors retinopathy progression, and EyeApp, a mobile application facilitating diabetic retinopathy screening via smartphones. Additionally, Eyenuk provides EyeSeeAMD, a technology designed to identify age-related macular degeneration. Through its advanced solutions, Eyenuk aims to ensure timely diagnosis of life- and vision-threatening conditions, including glaucoma and cardiovascular risks, ultimately striving to screen every eye globally.

Alydia Health, Inc. is a medical device company focused on addressing postpartum hemorrhage (PPH), a leading cause of maternal mortality. Founded in 2010 and based in Menlo Park, California, the company designs and manufactures the Jada System, a device that helps control excessive bleeding after childbirth by promoting normal uterine contractions. This innovative approach provides an effective solution without the need for pharmaceuticals, hysterectomy, or other surgical interventions, thereby improving treatment options for women experiencing PPH. Alydia Health aims to significantly enhance the management of postpartum hemorrhage, ultimately improving maternal health outcomes worldwide.

Komaza is a tech-driven sustainable forestry company founded in 2006 by Tevis Howard. It focuses on transforming the wood industry in Africa through its innovative farmer platform, which integrates technology, training, and services. By partnering with rural farmers to establish virtual plantations and plant woodlots, Komaza aims to create a sustainable wood supply while significantly reducing costs compared to traditional plantations. This approach not only addresses the growing demand for wood and wood products but also empowers small-holder farmers, enabling them to contribute to solving the wood supply crisis in the region.

Acciona is a leading Spanish corporation specializing in sustainable solutions for infrastructure and renewable energy projects. Established over a century ago, it employs more than 30,000 people and operates in over 30 countries across five continents. The company is structured into two main divisions: energy and infrastructure. The energy division emphasizes renewable technologies, focusing on wind, solar, hydro, and biomass, while the infrastructure division includes construction, water treatment, and various service lines. Acciona undertakes projects through government concessions or independent opportunities, ensuring a commitment to sustainability through its Sustainability Master Plan, which aims to facilitate the transition to a low-carbon economy by optimizing resource use and minimizing environmental impact.

Dreams is a Neo-bank based in Stockholms Lan, Sweden, founded in 2013. The company operates a mobile application designed to simplify saving, spending, and lending money, making these financial activities more engaging and social for users. The app serves as a personal trainer for users' finances, providing motivation and support to help them achieve their savings goals. By breaking down larger financial objectives into manageable steps, Dreams empowers individuals to save for various aspirations, ultimately making their dreams more attainable.

Kley Group is a prominent French company specializing in the development and operation of student housing facilities. As the largest owner-operator in the sector, it provides a diverse range of accommodations, including studio, duet, and shared apartments. Kley Group focuses on creating living spaces that cater to modern student lifestyles, offering common areas designed to foster collaboration and community among residents. The company's mission is to ensure that students in France have access to high-quality housing options in their preferred locations.

SFR operates as a mobile telecommunications operator in France. The company offers mobile telephony services on post paid basis, and prepaid basis through phone cards; mobile multimedia services, such as music, television, video, and games; and data transmission services for residential, professional, and corporate customers. It also operates in the fixed-line telecommunication sector, including voice, data transmission, and broadband Internet access. The company was founded in 1987 and is based in Paris, France. SFR operates as a subsidiary of Vivendi.

Dreams is a Neo-bank based in Stockholms Lan, Sweden, founded in 2013. The company operates a mobile application designed to simplify saving, spending, and lending money, making these financial activities more engaging and social for users. The app serves as a personal trainer for users' finances, providing motivation and support to help them achieve their savings goals. By breaking down larger financial objectives into manageable steps, Dreams empowers individuals to save for various aspirations, ultimately making their dreams more attainable.

Roxy is a female sports fashion clothing brand based in Costa Mesa, California, specializing in an extensive range of apparel and accessories. The company offers an online shopping platform where customers can explore various product categories, including clothing, swimwear, footwear, and accessories. Roxy's collection features dresses, tops, tees, tanks, fleece, hoodies, jackets, pants, shorts, and loungewear, alongside a diverse selection of accessories such as handbags, backpacks, hats, and footwear options like sneakers, boots, and sandals. By providing a wide array of choices, Roxy caters to the fashion needs and preferences of its customers, promoting an active and stylish lifestyle.